| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/07/2010 | EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 04/07/2010 | EP2170335A1 Compositions comprising tryptophan hydroxylase inhibitors |
| 04/07/2010 | EP2170327A2 Use of dopamine stabilizers |
| 04/07/2010 | EP2170324A1 Compositions and methods for treating and preventing migrainous headaches and associated symptoms |
| 04/07/2010 | EP2170322A1 METHODS OF MODIFYING AMYLOID ß OLIGOMERS USING NON-PEPTIDIC COMPOUNDS |
| 04/07/2010 | EP2170320A1 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 04/07/2010 | EP2170316A1 Improving memory in subjects with mini-mental state examination of 24-26 |
| 04/07/2010 | EP2170310A2 Quick dissolve compositions of memantine hydrochloride |
| 04/07/2010 | EP2170297A2 Duloxetine formulation |
| 04/07/2010 | EP2170291A1 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof |
| 04/07/2010 | EP2170064A1 6.5-pyrrolopiperidine tachykinin receptor antagonists |
| 04/07/2010 | EP2170061A1 Substituted pyrrolidine compounds with central nervous system activity |
| 04/07/2010 | EP2032575B1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivative and its medical use |
| 04/07/2010 | EP1948607B1 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 04/07/2010 | EP1934214B1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | EP1313499B1 Method for treating the central nervous system by administration of igf structural analogs |
| 04/07/2010 | EP1255824B1 Transgenic mice for the study of neurodegenerative syndromes |
| 04/07/2010 | CN201436037U Smoking abatement and cigarette replacement device |
| 04/07/2010 | CN1973872B Medicine for nourishing Yin, invigorating kidney, strengthening physique and nourishing brain and its prepn |
| 04/07/2010 | CN1939439B Juglone and jujube capsules with memory-improving function and preparation thereof |
| 04/07/2010 | CN101691370A Triazolo[4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 04/07/2010 | CN101690814A Traditional Chinese medicine monomer having function of promoting growth of motoneuron |
| 04/07/2010 | CN101690804A Medicinal preparations for treating cerebral diseases by transtympanic administration |
| 04/07/2010 | CN101690791A Traditional Chinese medicine for treating epidemic encephalitis B |
| 04/07/2010 | CN101690790A Drug for curing Japanese B encephalitis (JBE) in critical period |
| 04/07/2010 | CN101690770A Preparation capable of reducing blood pressure and blood lipid and improving human immunity, and preparation method thereof |
| 04/07/2010 | CN101690765A Traditional Chinese medicine preparation for treating nervous depression |
| 04/07/2010 | CN101690762A Oral preparation for curing nerve ending diseases and Raynaud disease |
| 04/07/2010 | CN101690749A Traditional Chinese medicine composite for treating insomnia |
| 04/07/2010 | CN101690732A Rana chensinensis egg oil health care product and preparation method thereof |
| 04/07/2010 | CN101690723A 琥珀酸舒马普坦复方制剂及其制备方法 Sumatriptan succinate compound and its preparation method |
| 04/07/2010 | CN101690588A Composition comprising probiotics and tea extract and application thereof |
| 04/07/2010 | CN101015698B Medicament using rare earth transferring complex compound as vector |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7692011 8-hydroxy and 8-mercapto quinazolinones |
| 04/06/2010 | US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 04/06/2010 | US7691992 Nucleic acids encoding the human ALEX1 protein |
| 04/06/2010 | US7691974 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/06/2010 | US7691973 GFRα3 polypeptides |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691900 nervous system disorders; by reducing activation of the microglia an/or astrocytes and/or by reducing reactive gliosis; |
| 04/06/2010 | US7691897 Therapeutic agent |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691884 Heterocyclic sulfonamide inhibitors of β amyloid production |
| 04/06/2010 | US7691874 Treating symptoms of Parkinson's disease comprising administering an effective anti-Parkinsonism amount of 3-hydroxymorphinan (Norlevophanol); neuroprotectantsside effect reduction; cognition activators; Alzheimer's disease; drug abusepsychological disorders |
| 04/06/2010 | US7691857 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain |
| 04/06/2010 | US7691853 Pyrazole compounds useful as protein kinase inhibitors |
| 04/06/2010 | US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure |
| 04/06/2010 | US7691808 Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction |
| 04/06/2010 | CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 04/06/2010 | CA2459009C Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/06/2010 | CA2449899C Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/06/2010 | CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 04/06/2010 | CA2188919C Monoclonal antibodies which promote central nervous system remyelination |
| 04/01/2010 | WO2010036977A2 Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions |
| 04/01/2010 | WO2010036773A1 Deuterated l-aryl-2 -aminomethyl cyclopropane carboxyamide derivatives |
| 04/01/2010 | WO2010036631A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036141A1 An implantable neuroendoprosthesis system, a method for preparing same and a procedure for performing of a reconstructive neurosurgical operation |
| 04/01/2010 | WO2010036052A2 Composition containing 4-o-methylhonokiol for treating or preventing amyloid- related diseases |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | WO2010035750A1 Method for producing lipid |
| 04/01/2010 | WO2010035749A1 Method for concentrating lipid |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 04/01/2010 | WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035220A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035166A1 Benzamide derivatives |
| 04/01/2010 | WO2010035111A1 A process for the preparation of rotigotine |
| 04/01/2010 | WO2010035026A1 Use of nmda activity enhancers to treat hypersomnia, reduced wakefulness or reduced vigilance |
| 04/01/2010 | WO2010034863A1 Use of kinase inhibitors for the preparation of pharmaceutical compositions for treatment of parkinson’s disease, pharmaceutical compositions and diagnostic procedure for parkinson’s disease |
| 04/01/2010 | WO2010034707A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 04/01/2010 | WO2010034706A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 04/01/2010 | WO2010034656A1 Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulatorsof dopamine d3 receptors |
| 04/01/2010 | WO2010034648A1 Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors |
| 04/01/2010 | WO2010034646A1 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors |
| 04/01/2010 | WO2010034315A1 A deproteinised calf blood preparation for use in prevention or treatment of diabetic peripheral polyneuropathy |
| 04/01/2010 | WO2010015965A3 Methods and compositions for treating neuronal damage and modulating transient receptor potential channels |
| 04/01/2010 | WO2010011626A3 Pyridinyl modulators of ϒ-secretase |
| 04/01/2010 | WO2010010157A3 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1 |
| 04/01/2010 | WO2009156864A3 Substituted alkyl pyrimidin-4-one derivatives |
| 04/01/2010 | WO2009156861A3 Substituted pyrimidone derivatives |
| 04/01/2010 | WO2009149435A3 Promoting axon regeneration in the adult cns through control of protein translation |
| 04/01/2010 | WO2009147234A3 Anxiolytic composition containing alphas1-casein-derived peptides |
| 04/01/2010 | WO2009143064A3 Rice bran extracts for inflammation and methods of use thereof |
| 04/01/2010 | WO2009143019A3 Method of treating peripheral nerve sensory loss using compounds having nicotinic acetylcholine receptor activity |
| 04/01/2010 | WO2009138762A3 Therapeutic use of peptides |
| 04/01/2010 | WO2009133521A3 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
| 04/01/2010 | WO2008139845A8 Novel amide derivative |
| 04/01/2010 | US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 04/01/2010 | US20100081723 Memantine For The Treatment Of Childhood Behavioral Disorders |
| 04/01/2010 | US20100081722 Composition and method for neuroprotection against excitotoxic injury |
| 04/01/2010 | US20100081719 Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome |
| 04/01/2010 | US20100081718 Combinations comprising alpha-2-delta ligands |
| 04/01/2010 | US20100081705 Methods for slowing familial als disease progression |
| 04/01/2010 | US20100081690 Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |